Equity Analysis

Quarterly Results

    Sandu Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524703
    INE751D01014
    42.2883059
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    37.1
    54.48
    EPS(TTM)
    Face Value()
    Div & Yield %:
    1.52
    10
    1.42
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales17.7017.0515.60
Other Operating Income0.000.000.00
Other Income 0.030.040.31
Total Income17.7317.0915.90
Total Expenditure 16.7916.6414.99
PBIDT0.950.450.91
Interest 0.030.020.01
PBDT0.920.430.90
Depreciation0.170.160.19
Tax0.210.080.21
Fringe Benefit Tax0.000.000.00
Deferred Tax0.030.03-0.09
Reported Profit After Tax0.500.170.59
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item0.500.170.59
EPS (Unit Curr.)0.520.170.50
EPS (Adj) (Unit Curr.)0.520.170.50
Calculated EPS (Unit Curr.)0.520.170.61
Calculated EPS (Adj) (Unit Curr.)0.520.170.61
Calculated EPS (Ann.) (Unit Curr.)2.070.692.45
Calculated EPS (Adj) (Ann.) (Unit Curr.)2.070.692.45
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity9.669.669.66
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)5.372.645.83
PBDTM(%)5.202.525.77
PATM(%)2.821.003.78
Dividend Per Share(Rs)0.000.000.00
Diluted EPS0.520.170.50